1.
Product Overview
2.
Research Methodology
3.
Impact of COVID-19 on Global Drug Discovery Informatics
4. Executive Summary
5.
Voice of Customer
6. Global Drug
Discovery Informatics Market Outlook
6.1.
Market Size & Forecast
6.1.1.
By Value
6.2.
Market Share & Forecast
6.2.1. By Component (Software v/s Service)
6.2.2. By Function (Sequencing and Target Data Analysis,
Docking, Molecular Modelling, Library & Database Preparation, Clinical
Trial Data Management, Others)
6.2.3. By Mode (In-house Informatics v/s Outsourced)
6.2.4. By Application (Drug Discovery v/s Drug Development)
6.2.5. By End User (Pharmaceutical Companies, Biotechnology
Companies, Contract Research Organization (CROs), Others)
6.2.6.
By Company (2019)
6.2.7. By Region
6.3.
Product Market Map
7. Asia-Pacific Drug
Discovery Informatics Market Outlook
7.1.
Market Size & Forecast
7.1.1.
By Value
7.2.
Market Share & Forecast
7.2.1. By Component
7.2.2. By Function
7.2.3. By Mode
7.2.4. By Application
7.2.5. By End User
7.2.6.
By Country
7.3.
Asia-Pacific: Country Analysis
7.3.1.
China Drug Discovery Informatics Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Component
7.3.1.2.2.
By Function
7.3.1.2.3.
By Mode
7.3.1.2.4.
By Application
7.3.1.2.5.
By End User
7.3.2.
India Drug Discovery Informatics Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Component
7.3.2.2.2.
By Function
7.3.2.2.3.
By Mode
7.3.2.2.4.
By Application
7.3.2.2.5.
By End User
7.3.3.
Australia Drug Discovery Informatics Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Component
7.3.3.2.2.
By Function
7.3.3.2.3.
By Mode
7.3.3.2.4.
By Application
7.3.3.2.5.
By End User
7.3.4.
Japan Drug Discovery Informatics Market Outlook
7.3.4.1.
Market Size & Forecast
7.3.4.1.1.
By Value
7.3.4.2.
Market Share & Forecast
7.3.4.2.1.
By Component
7.3.4.2.2.
By Function
7.3.4.2.3.
By Mode
7.3.4.2.4.
By Application
7.3.4.2.5.
By End User
7.3.5.
South Korea Drug Discovery Informatics
Market Outlook
7.3.5.1.
Market Size & Forecast
7.3.5.1.1.
By Value
7.3.5.2.
Market Share & Forecast
7.3.5.2.1.
By Component
7.3.5.2.2.
By Function
7.3.5.2.3.
By Mode
7.3.5.2.4.
By Application
7.3.5.2.5.
By End User
8. Europe Drug Discovery
Informatics Market Outlook
8.1.
Market Size & Forecast
8.1.1.
By Value
8.2.
Market Share & Forecast
8.2.1.
By Component
8.2.2.
By Function
8.2.3.
By Mode
8.2.4.
By Application
8.2.5.
By End User
8.2.6.
By Country
8.3.
Europe: Country Analysis
8.3.1.
France Drug Discovery Informatics Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Component
8.3.1.2.2.
By Function
8.3.1.2.3.
By Mode
8.3.1.2.4.
By Application
8.3.1.2.5.
By End User
8.3.2.
Germany Drug Discovery Informatics Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Component
8.3.2.2.2.
By Function
8.3.2.2.3.
By Mode
8.3.2.2.4.
By Application
8.3.2.2.5.
By End User
8.3.3.
United Kingdom Drug Discovery Informatics
Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Component
8.3.3.2.2.
By Function
8.3.3.2.3.
By Mode
8.3.3.2.4.
By Application
8.3.3.2.5.
By End User
8.3.4.
Italy Drug Discovery Informatics Market Outlook
8.3.4.1.
Market Size & Forecast
8.3.4.1.1.
By Value
8.3.4.2.
Market Share & Forecast
8.3.4.2.1.
By Component
8.3.4.2.2.
By Function
8.3.4.2.3.
By Mode
8.3.4.2.4.
By Application
8.3.4.2.5.
By End User
8.3.5.
Spain Drug Discovery Informatics Market Outlook
8.3.5.1.
Market Size & Forecast
8.3.5.1.1.
By Value
8.3.5.2.
Market Share & Forecast
8.3.5.2.1.
By Component
8.3.5.2.2.
By Function
8.3.5.2.3.
By Mode
8.3.5.2.4.
By Application
8.3.5.2.5.
By End User
9. North America Drug
Discovery Informatics Market Outlook
9.1.
Market Size & Forecast
9.1.1.
By Value
9.2.
Market Share & Forecast
9.2.1.
By Component
9.2.2.
By Function
9.2.3.
By Mode
9.2.4.
By Application
9.2.5.
By End User
9.2.6.
By Country
9.3.
North America: Country Analysis
9.3.1.
United States Drug Discovery Informatics
Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Component
9.3.1.2.2.
By Function
9.3.1.2.3.
By Mode
9.3.1.2.4.
By Application
9.3.1.2.5.
By End User
9.3.2.
Mexico Drug Discovery Informatics Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Component
9.3.2.2.2.
By Function
9.3.2.2.3.
By Mode
9.3.2.2.4.
By Application
9.3.2.2.5.
By End User
9.3.3.
Canada Drug Discovery Informatics Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Component
9.3.3.2.2.
By Function
9.3.3.2.3.
By Mode
9.3.3.2.4.
By Application
9.3.3.2.5.
By End User
10. South America Drug
Discovery Informatics Market Outlook
10.1.
Market Size & Forecast
10.1.1.
By Value
10.2.
Market Share & Forecast
10.2.1.
By Component
10.2.2.
By Function
10.2.3.
By Mode
10.2.4.
By Application
10.2.5.
By End User
10.2.6.
By Country
10.3.
South America: Country Analysis
10.3.1.
Brazil Drug Discovery Informatics Market Outlook
10.3.1.1.
Market Size & Forecast
10.3.1.1.1.
By Value
10.3.1.2.
Market Share & Forecast
10.3.1.2.1.
By Component
10.3.1.2.2.
By Function
10.3.1.2.3.
By Mode
10.3.1.2.4.
By Application
10.3.1.2.5.
By End User
10.3.2.
Argentina Drug Discovery Informatics Market Outlook
10.3.2.1.
Market Size & Forecast
10.3.2.1.1.
By Value
10.3.2.2.
Market Share & Forecast
10.3.2.2.1.
By Component
10.3.2.2.2.
By Function
10.3.2.2.3.
By Mode
10.3.2.2.4.
By Application
10.3.2.2.5.
By End User
10.3.3.
Colombia Drug Discovery Informatics Market Outlook
10.3.3.1.
Market Size & Forecast
10.3.3.1.1.
By Value
10.3.3.2.
Market Share & Forecast
10.3.3.2.1.
By Component
10.3.3.2.2.
By Function
10.3.3.2.3.
By Mode
10.3.3.2.4.
By Application
10.3.3.2.5.
By End User
11. Middle East and
Africa Drug Discovery Informatics Market Outlook
11.1.
Market Size & Forecast
11.1.1.
By Value
11.2.
Market Share & Forecast
11.2.1.
By Component
11.2.2.
By Function
11.2.3.
By Mode
11.2.4.
By Application
11.2.5.
By End User
11.2.6.
By Country
11.3.
MEA: Country Analysis
11.3.1.
South Africa Drug Discovery Informatics
Market Outlook
11.3.1.1.
Market Size & Forecast
11.3.1.1.1.
By Value
11.3.1.2.
Market Share & Forecast
11.3.1.2.1.
By Component
11.3.1.2.2.
By Function
11.3.1.2.3.
By Mode
11.3.1.2.4.
By Application
11.3.1.2.5.
By End User
11.3.2.
Saudi Arabia Drug Discovery Informatics
Market Outlook
11.3.2.1.
Market Size & Forecast
11.3.2.1.1.
By Value
11.3.2.2.
Market Share & Forecast
11.3.2.2.1.
By Component
11.3.2.2.2.
By Function
11.3.2.2.3.
By Mode
11.3.2.2.4.
By Application
11.3.2.2.5.
By End User
11.3.3.
UAE Drug Discovery Informatics Market Outlook
11.3.3.1.
Market Size & Forecast
11.3.3.1.1.
By Value
11.3.3.2.
Market Share & Forecast
11.3.3.2.1.
By Component
11.3.3.2.2.
By Function
11.3.3.2.3.
By Mode
11.3.3.2.4.
By Application
11.3.3.2.5.
By End User
11.3.4.
Kuwait Drug Discovery Informatics Market Outlook
11.3.4.1.
Market Size & Forecast
11.3.4.1.1.
By Value
11.3.4.2.
Market Share & Forecast
11.3.4.2.1.
By Component
11.3.4.2.2.
By Function
11.3.4.2.3.
By Mode
11.3.4.2.4.
By Application
11.3.4.2.5.
By End User
12.
Market Dynamics
12.1.
Drivers
12.2.
Challenges
13.
Market Trends & Developments
14.
Competitive Landscape
14.1.
Jubilant Life Sciences Limited
14.2.
IBM Corporation
14.3.
Clarivate Analytics
14.4.
Eurofins Scientific
14.5.
Thermo Fisher Scientific
14.6.
Accenture PLC
14.7.
PerkinElmer Inc
14.8.
Schrödinger, Inc.
14.9.
Certara L.P.
14.10.
Evotec AG
15. Strategic Recommendations
16. About Us & Disclaimer